Abstract:BACKGROUND AND OBJECTIVES: <AbstractText Label="BACKGROUND AND OBJECTIVES">The high risk of cardiovascular disease (CVD) and premature death in patients with CKD associates with a plethora of elevated circulating biomarkers that may reflect distinct signaling pathways or simply, are epiphenomena of CKD. We compared the predictive strength of 12 biomarkers analyzed concomitantly in patients with stage 5 CKD.</AbstractText>DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: <AbstractText Label="DESIGN, SETTING, PARTICIPANTS, &amp; MEASUREMENTS">From 1994 to 2014, 543 patients with stage 5 CKD (median age =56 years old; 63% men; 199 patients had CVD) took part in our study on malnutrition, inflammation, and CVD in incident dialysis patients. Circulating levels of albumin, ferritin, high-sensitivity C-reactive protein (hsCRP), IGF-1, IL-6, orosomucoid, troponin T (TnT), TNF, soluble intracellular adhesion molecule, soluble vascular cellular adhesion molecule 1 (sVCAM-1), and platelet and white blood cell (WBC) counts were analyzed as predictors of the presence of clinically overt CVD at baseline, protein-energy wasting (PEW), and subsequent all-cause mortality. During follow-up for a median of 28 months, there were 149 deaths, 81 of which were caused by CVD.</AbstractText>RESULTS: <AbstractText Label="RESULTS">Most biomarkers were elevated compared with reference values and--except for albumin, ferritin, and IGF-1-higher in patients with CVD. In receiver operating characteristic analysis, age, IL-6, TnT, hsCRP, and IGF-1 were classifiers of baseline CVD and predictors of all-cause mortality. In addition to age, diabetes mellitus, smoking (for CVD), and PEW, only IL-6, relative risk (RR) 1.10 and 95% confidence interval ([95% CI], 1.02 to 1.19), sVCAM-1 RR 1.09 (95% CI, 1.01 to 1.17), and serum albumin RR 0.89 (95% CI, 0.83 to 0.95) associated with baseline CVD, and only WBC, hazard ratio (HR) 1.94 (95% CI, 1.34 to 2.82), IL-6 HR 1.79 (95% CI, 1.20 to 2.67), and TNF HR 0.65 (95% CI, 0.44 to 0.97) predicted all-cause mortality.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS">In addition to age and comorbidities, only IL-6, sVCAM-1, and albumin could-independently of other biomarkers-classify clinical CVD, and only IL-6, WBC, and TNF could-independently of other biomarkers-predict all-cause mortality risk. These data underscore the robustness of IL-6 as a classifier of clinically overt CVD and predictor of all-cause mortality in patients with stage 5 CKD.</AbstractText>

Copeptin associates with major adverse cardiovascular events in patients on maintenance hemodialysis

Predicting Cardiovascular Mortality in Chronic Kidney Disease (CKD) Patients.

Copeptin is associated with mortality in patients with traumatic brain injury.

Renal Function Interferes with Copeptin in Prediction of Major Adverse Cardiac Events in Patients Undergoing Vascular Surgery

Change in Plasma Copeptin Level after Acute Spontaneous Basal Ganglia Hemorrhage

Copeptin: a new marker in cardiology

Association Between Circulating Copeptin Level and Mortality Risk in Patients with Intracerebral Hemorrhage: a Systemic Review and Meta-Analysis

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease

Clinical value of serum copeptin on risk stratification and prognosis in patients with acute coronary syndrome

Prognostic value of copeptin in patients with acute myocardial infarction treated with percutaneous coronary intervention: a prospective cohort study

Copeptin as a potential biomarker of chronic kidney disease to predict the disease progression in children with chronic kidney disease

Prognostic Efficacy of Combined Index of Cardiac Biomarkers for Cardiovascular and All-Cause Mortality on Hemodialysis Patients

The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study

Plasma Levels of Copeptin in Patients with Coronary Heart Disease

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD

Mortality and Associated Risk Factors in Dialysis Patients with Cardiovascular Disease

Detection of Copeptin in Peripheral Blood of Patients with Aneurysmal Subarachnoid Hemorrhage.

Association of Preoperative Copeptin Levels with Risk of All-Cause Mortality in a Prospective Cohort of Adult Cardiac Surgery Patients

The short-term prediction of high-sensitivity cardiac troponin T in patients undergoing maintenance hemodialysis

NT-proBNP and Stem Cell Factor Plasma Concentrations Are Independently Associated with Cardiovascular Outcomes in End-Stage Renal Disease Hemodialysis Patients.

A Joint Evaluation of Neurohormone Vasopressin-Neurophysin II-Copeptin and Aortic Arch Calcification on Mortality Risks in Hemodialysis Patients